Naman Kumar Pandit
About Naman Kumar Pandit
Naman Kumar Pandit is a Senior Solutions Consultant with over 10 years of experience in the mammalian cell culture industry, specializing in monoclonal antibodies. He has held various roles at notable companies such as Biocon Biologics and Dr. Reddy's Laboratories, and he aims to enhance the accessibility of affordable quality biopharmaceutical products.
Work at ComplianceQuest
Naman Kumar Pandit serves as a Senior Solutions Consultant at ComplianceQuest since 2023. In this role, he utilizes his extensive experience in the biopharmaceutical industry to provide solutions that enhance operational efficiency and product quality. His expertise in mammalian cell culture and monoclonal antibodies supports ComplianceQuest's mission to deliver innovative solutions in compliance and quality management.
Professional Experience in Biopharmaceutical Industry
Naman Kumar Pandit has over 10 years of experience in the mammalian cell culture industry. He has held various positions at notable companies, including Biocon Biologics, Dr. Reddy's Laboratories, and Kemwell Biopharma. His roles have included Senior Executive and Assistant Manager at Biocon Biologics, where he focused on production and quality aspects of monoclonal antibodies. He also worked as a Production Specialist at Dr. Reddy's Laboratories and as a Junior Executive at Kemwell Biopharma.
Educational Background
Naman Kumar Pandit holds a Bachelor of Science (BS) and a Master of Science (MS) in Biotechnology from Magadh University, where he studied from 2006 to 2011. He also earned a Post Graduate Diploma in Protein Expression and Scale Up from the University of Mysore in 2013. Additionally, he completed a Master of Business Administration (MBA) in Manufacturing Management from Birla Institute of Technology and Science, Pilani, from 2016 to 2018.
Career Goals in Biopharmaceuticals
Naman Kumar Pandit aims to contribute further to the biopharmaceutical industry by focusing on making affordable and quality products accessible to patients worldwide. His extensive background in production, scale-up, and quality assurance positions him to impact the industry positively.